Summary & Overview
CPT 4045F: Unassigned CPT Measure
CPT code 4045F is listed without a descriptive summary in the provided source. As a CPT-coded item, it represents a procedure or clinical performance/encounter measure that can affect billing, reporting, and clinical documentation workflows nationwide. Understanding the role of an un-summarized CPT code is important for payers, providers, and billing teams to ensure accurate claims submission and to avoid denials tied to ambiguous or undocumented codes.
Key payers considered in the national context include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what 4045F signifies, how it may be used in clinical and billing settings, and what information is missing from the source that would normally inform coding practice. The publication outlines where benchmarks and policy updates are relevant, highlights implications for documentation and claims processing, and identifies gaps that require reference to official CPT resources or payer guidance.
This summary is written for a national audience and focuses on code interpretation, administrative impacts, and the types of follow-up information that stakeholders typically seek when a CPT code lacks a published description.
Billing Code Overview
CPT code 4045F has no summary available in the source description. Based on the code label, this entry represents a CPT performance or encounter-related measure without an assigned plain-language summary.
Service Type: Data not available in the input.
Typical Site of Service: Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 52-year-old presenting to an outpatient otolaryngology clinic with a slowly enlarging, painful mass of the parotid gland area or suspicious lesion discovered on imaging. The clinical workflow includes history and physical focusing on salivary gland symptoms, ultrasonography or MRI to define lesion size and location, fine-needle aspiration (FNA) or core needle biopsy for cytology if indicated, preoperative counseling, and scheduling for surgical excision (superficial or total parotidectomy) or biopsy. The procedure is typically performed in an ambulatory surgery center or hospital outpatient department under general anesthesia. Perioperative documentation includes informed consent, operative note describing extent of gland excision, facial nerve identification and preservation, specimens submitted to pathology, and immediate postoperative instructions for wound care and facial nerve monitoring. Follow-up includes pathology review, potential adjuvant therapy planning, and outpatient wound and facial nerve function assessment.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
24 | Unrelated evaluation and management service by the same physician during a postoperative period | Use when an unrelated E/M occurs during global surgical period for post-op complications unrelated to the surgery |
25 |